Related Experiment Video
Updated: Nov 12, 2025

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Infective Endocarditis Due to Corynebacterium Species: Clinical Features and Antibiotic Resistance
Anna Bläckberg1,2, Linn Falk1, Karl Oldberg1,3
1Division of Infection Medicine, Department of Clinical Sciences Lund, Lund University, Sweden.
Background:
Corynebacterium species are often dismissed as contaminants in blood cultures, but they can also cause infective endocarditis (IE), which is a severe condition. Antibiotic resistance of corynebacteria is increasing making treatment challenging. Reports on IE caused by Corynebacterium species are scarce and more knowledge is needed.
Methods:
Cases of IE caused by Corynebacterium species were identified through the Swedish Registry of Infective Endocarditis. Isolates were collected for species redetermination by matrix-assisted laser desorption ionization-time of flight and for antibiotic susceptibility testing using Etests.
Results:
Thirty episodes of IE due to Corynebacterium species were identified between 2008 and 2017. The median age of patients was 71 years (interquartile range, 60-76) and 77% were male. Corynebacterium striatum (n = 11) was the most common IE causing pathogen followed by Corynebacterium jeikeium (n = 5). Surgery was performed in 50% and in-hospital mortality rate was 13%. Patients with IE caused by Corynebacterium species were significantly more likely to have prosthetic valve endocarditis (70%), compared with patients with IE due to Staphylococcus aureus or non-beta-hemolytic streptococci (14% and 26%, respectively) (P < .0001). Vancomycin was active towards all Corynebacterium isolates, whereas resistance towards penicillin G was common.
Conclusions:
Corynebacterium species cause IE, where prosthetic valves are mainly affected and surgery is often performed. Corynebacterium striatum is an important causative agent of IE within the genus. Antibiotic resistance of corynebacteria is relatively common but resistance towards vancomycin could not be detected in vitro.
Insights
Corynebacterium species can cause severe infective endocarditis (IE), particularly in patients with prosthetic valves. While antibiotic resistance is common, vancomycin remains effective against these challenging IE pathogens.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Corynebacterium species, often overlooked as contaminants, are increasingly recognized as significant pathogens causing infective endocarditis (IE).
- Rising antibiotic resistance in Corynebacterium complicates treatment strategies for IE.
- Limited data exists on IE caused by Corynebacterium species, necessitating further investigation.
Purpose of the Study:
- To investigate the clinical characteristics and outcomes of infective endocarditis (IE) caused by Corynebacterium species.
- To identify the most common Corynebacterium species implicated in IE.
- To assess the antibiotic susceptibility patterns of these isolates.
Main Methods:
- Retrospective analysis of IE cases caused by Corynebacterium species from the Swedish Registry of Infective Endocarditis (2008-2017).
- Species identification using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF).
- Antibiotic susceptibility testing performed using Etests.
Main Results:
- Thirty episodes of Corynebacterium IE were identified, predominantly in elderly males (median age 71, 77% male).
- Corynebacterium striatum (n=11) and Corynebacterium jeikeium (n=5) were the most frequent species.
- Prosthetic valve endocarditis was common (70%), with a 13% in-hospital mortality rate. Vancomycin showed universal in vitro activity, while penicillin G resistance was frequent.
Conclusions:
- Corynebacterium species are significant causative agents of infective endocarditis, particularly affecting prosthetic valves and often requiring surgical intervention.
- Corynebacterium striatum is a key pathogen within this genus responsible for IE.
- While antibiotic resistance is prevalent, vancomycin remains a reliable treatment option in vitro.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Bacterial Phylum Actinobacteria
Myocarditis II: Clinical Features and Diagnostic Tests